LambdaBiologics is supporting toxicity evaluation and efficacy verification for pet pharmaceutical products and functional foods through its innovative organoid platform, offering an alternative to animal testing.
Platform Potential Proven Through Toxicity Evaluation of Pet Toothpaste
LambdaBiologics organoid platform was recently utilized for the toxicity evaluation of a pet toothpaste product. Due to pets nature, these kind of toothpaste products are ought to be frequently ingested by animals, yet there is no regulatory obligation for toxicity evaluation. To enhance animal health and product reliability, the company adopted LambdaBiologics organoid platform. The following contributions were made:
- Safety Confirmation: By using intestinal organoids, the platform analyzed product absorption and toxicity data, confirming significantly lower toxicity compared to competitor products.
- Marketing Utilization: These evaluation results have contributed by emphasizing product safety and strengthening consumer trust.
Collaboration Shaping the Future of Pet Products
Through its organoid platform, LambdaBiologics is setting a new standard in toxicity evaluation for pet pharmaceutical products and functional items. The combination of innovative technology and a data-driven approach plays a critical role in helping clients achieve a competitive edge with differentiated products.